WHSC1/NSD2 regulates immune infiltration in prostate cancer

BACKGROUND: Immunotherapy in prostate cancer (PCa) lags behind the progresses obtained in other cancer types partially because of its limited immune infiltration. Tumor-resident immune cells have been detected in the prostate, but the regulatory mechanisms that govern tumor infiltration are still po...

Descripción completa

Detalles Bibliográficos
Autores principales: Want, Muzamil Y, Tsuji, Takemasa, Singh, Prashant K, Thorne, James L, Matsuzaki, Junko, Karasik, Ellen, Gillard, Bryan, Cortes Gomez, Eduardo, Koya, Richard C., Lugade, Amit, Odunsi, Kunle, Battaglia, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887377/
https://www.ncbi.nlm.nih.gov/pubmed/33589522
http://dx.doi.org/10.1136/jitc-2020-001374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887377/
https://www.ncbi.nlm.nih.gov/pubmed/33589522
http://dx.doi.org/10.1136/jitc-2020-001374

Ejemplares similares